Conditions

Subcategories:Axial Spondyloarthritis Gout and Crystalline Arthritis Guidelines Myositis Osteoarthritis and Bone Disorders Other Rheumatic Conditions Pain Syndromes Pediatric Conditions Psoriatic Arthritis Rheumatoid Arthritis Sjögren’s Disease Soft Tissue Pain Systemic Lupus Erythematosus Systemic Sclerosis Vasculitis

New Hydrogel May Offer Promising Osteoarthritis Treatment

Kurt Ullman | January 16, 2013

A new hydrogel that can be stretched and is self-healing might become an effective ligament repair option in osteoarthritis (OA).

Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients

Lara C. Pullen, PhD | January 2, 2013

In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.

A Spotlight on IgG4-Related Disease

Emine Atac, MD, and John H. Stone, MD, MPH | January 1, 2013

What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)

ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront

Mary Beth Nierengarten | January 1, 2013

Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights

ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?

Thomas R. Collins | January 1, 2013

Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit

ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis

Thomas R. Collins | January 1, 2013

Rheumatology experts urge caution in using bisphosphonates to prevent bone loss

ACR/ARHP Annual Meeting 2012: How to Manage Gout Effectively in the Context of Comorbid Conditions

Mary Beth Nierengarten | January 1, 2013

Comorbid conditions such as chronic kidney disease and cardiovascular disease can complicate gout management, but effective treatment and preventive strategies are available

What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

Aryeh Fischer, MD, and Jeff Swigris, DO, MS | December 1, 2012

Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)

Foundation Research Explores Relationship Between RA and Cardiovascular Disease

Staff | December 1, 2012

A grant from the Rheumatology Research Foundation has set two physicians on a course to examine how high-density lipoprotein (HDL) cholesterol is different in rheumatoid arthritis patients

Coding Corner Answer: December Coding Challenge

Staff | December 1, 2012

Coding for an office visit by a patient with severe rheumatoid arthritis who experiences an adverse reaction to an infliximab infusion and has her IV flushed with saline and pushed with diphenhydramine.